Kinetics of Blood–Brain Barrier Transport of Monoclonal Antibodies Targeting the Insulin Receptor and the Transferrin Receptor

Pardridge, 2020, Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain, Front. Med. Technol., 2, 602236, 10.3389/fmedt.2020.602236

Giugliani, 2018, Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): An open label phase 1-2 trial, Orphanet J. Rare Dis., 13, 110, 10.1186/s13023-018-0849-8

Giugliani, 2021, Iduronate-2-sulfatase fused with anti-hTfR antibody, pabinafusp alfa, for MPS-II: A phase 2 trial in Brazil, Mol. Ther., 29, 2378, 10.1016/j.ymthe.2021.03.019

Okuyama, 2021, A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II, Mol. Ther., 29, 671, 10.1016/j.ymthe.2020.09.039

Giugliani, R., Martins, A.M., Okuyama, T., Eto, Y., Sakai, N., Nakamura, K., Morimoto, H., Minami, K., Yamamoto, T., and Yamaoka, M. (2021). Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data. Int. J. Mol. Sci., 22.

Ullman, 2020, Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice, Sci. Transl. Med., 12, eaay1163, 10.1126/scitranslmed.aay1163

Niewoehner, 2014, Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle, Neuron, 81, 49, 10.1016/j.neuron.2013.10.061

Sehlin, 2016, Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer’s disease, Nat. Commun., 7, 10759, 10.1038/ncomms10759

Sehlin, 2017, Pharmacokinetics, biodistribution and brain retention of a bispecific antibody-based PET radioligand for imaging of amyloid-beta, Sci. Rep., 7, 17254, 10.1038/s41598-017-17358-2

Sehlin, 2019, Engineered antibodies: New possibilities for brain PET?, Eur. J. Nucl. Med. Mol. Imaging, 46, 2848, 10.1007/s00259-019-04426-0

Syvanen, 2020, Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-beta in Brain, ACS Chem. Neurosci., 11, 4460, 10.1021/acschemneuro.0c00652

Kang, 2016, Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson’s Disease, CNS Neurosci. Ther., 22, 817, 10.1111/cns.12580

Gregori, 2016, Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes, J. Pharm. Sci., 105, 276, 10.1016/j.xphs.2015.11.009

Johnsen, 2019, Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo, J. Control Release, 295, 237, 10.1016/j.jconrel.2019.01.005

Thomsen, L.B., Linemann, T., Birkelund, S., Tarp, G.A., and Moos, T. (2019). Evaluation of Targeted Delivery to the Brain Using Magnetic Immunoliposomes and Magnetic Force. Materials, 12.

Loureiro, 2016, Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer’s disease treatment, Colloids Surf. B Biointerfaces, 145, 8, 10.1016/j.colsurfb.2016.04.041

Sahin, 2017, Evaluation of brain-targeted chitosan nanoparticles through blood-brain barrier cerebral microvessel endothelial cells, J. Microencapsul., 34, 659, 10.1080/02652048.2017.1375039

Ramalho, 2018, Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment, Int. J. Pharm., 545, 84, 10.1016/j.ijpharm.2018.04.062

Crook, 2020, A TfR-Binding Cystine-Dense Peptide Promotes Blood-Brain Barrier Penetration of Bioactive Molecules, J. Mol. Biol., 432, 3989, 10.1016/j.jmb.2020.04.002

Kariolis, 2020, Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys, Sci. Transl. Med., 12, eaay1359, 10.1126/scitranslmed.aay1359

Stocki, 2021, Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1, FASEB J., 35, e21172, 10.1096/fj.202001787R

Sehlin, 2020, Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle, FASEB J., 34, 13272, 10.1096/fj.202000610RR

Meister, S.W., Hjelm, L.C., Dannemeyer, M., Tegel, H., Lindberg, H., Stahl, S., and Lofblom, J. (2020). An Affibody Molecule Is Actively Transported into the Cerebrospinal Fluid via Binding to the Transferrin Receptor. Int. J. Mol. Sci., 21.

Pardridge, 2018, Blood-Brain Barrier Transport, Plasma Pharmacokinetics, and Neuropathology Following Chronic Treatment of the Rhesus Monkey with a Brain Penetrating Humanized Monoclonal Antibody Against the Human Transferrin Receptor, Mol. Pharm., 15, 5207, 10.1021/acs.molpharmaceut.8b00730

Sonoda, 2018, A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II, Mol. Ther., 26, 1366, 10.1016/j.ymthe.2018.02.032

Schwartz, 2018, Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration, mAbs, 10, 765, 10.1080/19420862.2018.1465159

Do, 2020, Tetravalent Bispecific Tandem Antibodies Improve Brain Exposure and Efficacy in an Amyloid Transgenic Mouse Model, Mol. Ther. Methods Clin. Dev., 19, 58, 10.1016/j.omtm.2020.08.014

Hultqvist, 2017, Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor, Theranostics, 7, 308, 10.7150/thno.17155

Yu, 2014, Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates, Sci. Transl. Med., 6, 261ra154, 10.1126/scitranslmed.3009835

Li, 2017, Preparation and Characterization of a Novel Monoclonal Antibody Against the Extracellular Domain of Human Transferrin Receptor, Monoclon. Antib. Immunodiagn. Immunother., 36, 1, 10.1089/mab.2016.0025

Thom, 2018, Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26, Mol. Pharm., 15, 1420, 10.1021/acs.molpharmaceut.7b00937

Chang, 2021, Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis, mAbs, 13, 1874121, 10.1080/19420862.2021.1874121

Yu, 2011, Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target, Sci. Transl. Med., 3, 84ra44, 10.1126/scitranslmed.3002230

Webster, 2017, Enhanced delivery of IL-1 receptor antagonist to the central nervous system as a novel anti-transferrin receptor-IL-1RA fusion reverses neuropathic mechanical hypersensitivity, Pain, 158, 660, 10.1097/j.pain.0000000000000810

Pardridge, W.M., and Chou, T. (2021). Mathematical Models of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Transferrin Receptor and the Insulin Receptor. Pharmaceuticals, 14.

Boado, 2017, Brain and Organ Uptake in the Rhesus Monkey In Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody-Iduronidase Fusion Protein, Mol. Pharm., 14, 1271, 10.1021/acs.molpharmaceut.6b01166

Eckenroth, 2011, How the binding of human transferrin primes the transferrin receptor potentiating iron release at endosomal pH, Proc. Natl. Acad. Sci. USA, 108, 13089, 10.1073/pnas.1105786108

Herbison, 2009, The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells, Am. J. Physiol. Cell. Physiol., 297, C1567, 10.1152/ajpcell.00649.2008

Pardridge, 2020, The Isolated Brain Microvessel: A Versatile Experimental Model of the Blood-Brain Barrier, Front. Physiol., 11, 398, 10.3389/fphys.2020.00398

Mason, 2009, A loop in the N-lobe of human serum transferrin is critical for binding to the transferrin receptor as revealed by mutagenesis, isothermal titration calorimetry, and epitope mapping, J. Mol. Recognit., 22, 521, 10.1002/jmr.979

Schmaier, 2020, Transferrin: A blood coagulation modifier, Cell. Res., 30, 101, 10.1038/s41422-020-0275-z

Ward, 2011, Landmarks in insulin research, Front. Endocrinol. (Lausanne), 2, 76, 10.3389/fendo.2011.00076

Lawrence, 2021, Understanding insulin and its receptor from their three-dimensional structures, Mol. Metab., 52, 101255, 10.1016/j.molmet.2021.101255

Gutmann, 2020, Cryo-EM structure of the complete and ligand-saturated insulin receptor ectodomain, J. Cell. Biol., 219, e201907210, 10.1083/jcb.201907210

Giudice, 2013, Insulin and insulin like growth factor II endocytosis and signaling via insulin receptor B, Cell. Commun. Signal., 11, 18, 10.1186/1478-811X-11-18

Menting, 2013, How insulin engages its primary binding site on the insulin receptor, Nature, 493, 241, 10.1038/nature11781

Bravo, 1994, Accurate and efficient cleavage of the human insulin proreceptor by the human proprotein-processing protease furin. Characterization and kinetic parameters using the purified, secreted soluble protease expressed by a recombinant baculovirus, J. Biol. Chem., 269, 25830, 10.1016/S0021-9258(18)47322-X

McKern, 2006, Structure of the insulin receptor ectodomain reveals a folded-over conformation, Nature, 443, 218, 10.1038/nature05106

Uchikawa, 2019, Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor-ligand complex, Elife, 8, e48630, 10.7554/eLife.48630

Bar, 1976, Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: Effects of starvation, refeeding, and dieting, J. Clin. Investig., 58, 1123, 10.1172/JCI108565

Bremer, 2011, Fructose-fed rhesus monkeys: A nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes, Clin. Transl. Sci., 4, 243, 10.1111/j.1752-8062.2011.00298.x

Giannetti, 2004, HFE and transferrin directly compete for transferrin receptor in solution and at the cell surface, J. Biol. Chem., 279, 25866, 10.1074/jbc.M401467200

Dodd, 1997, Concentrations of transferrin and carbohydrate-deficient transferrin in postmortem human brain from alcoholics, Addict. Biol., 2, 337, 10.1080/13556219772633

Sigurdsson, 2012, Brain tissue volumes in the general population of the elderly: The AGES-Reykjavik study, Neuroimage, 59, 3862, 10.1016/j.neuroimage.2011.11.024

Strahan, 1992, Iron uptake in relation to transferrin degradation in brain and other tissues of rats, Am. J. Physiol., 263, R924

Scapin, 2018, Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis, Nature, 556, 122, 10.1038/nature26153

Mandikian, 2018, Tissue Physiology of Cynomolgus Monkeys: Cross-Species Comparison and Implications for Translational Pharmacology, AAPS J., 20, 107, 10.1208/s12248-018-0264-z

Joris, P.J., Mensink, R.P., Adam, T.C., and Liu, T.T. (2018). Cerebral Blood Flow Measurements in Adults: A Review on the Effects of Dietary Factors and Exercise. Nutrients, 10.

Frank, 1985, Enhanced insulin binding to blood-brain barrier in vivo and to brain microvessels in vitro in newborn rabbits, Diabetes, 34, 728, 10.2337/diab.34.8.728

Sykova, 2008, Diffusion in brain extracellular space, Physiol. Rev., 88, 1277, 10.1152/physrev.00027.2007

Knopp, 2019, Insulin Units and Conversion Factors: A Story of Truth, Boots, and Faster Half-Truths, J. Diabetes Sci. Technol., 13, 597, 10.1177/1932296818805074

Duckworth, 1998, Insulin degradation: Progress and potential, Endocr. Rev., 19, 608

White, 1990, Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: Evidence for synergistic antiproliferative effects, Cancer Res., 50, 6295

Walus, 1996, Enhanced uptake of rsCD4 across the rodent and primate blood-brain barrier after conjugation to anti-transferrin receptor antibodies, J. Pharm. Exp. Ther., 277, 1067

Daniels, 2011, An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignancies, J. Immunother., 34, 500, 10.1097/CJI.0b013e318222ffc8

Helguera, 2012, An antibody recognizing the apical domain of human transferrin receptor 1 efficiently inhibits the entry of all new world hemorrhagic Fever arenaviruses, J. Virol., 86, 4024, 10.1128/JVI.06397-11

Steckbeck, 2005, Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strains, J. Virol., 79, 12311, 10.1128/JVI.79.19.12311-12320.2005

Encarnacao, 2017, Impact of assay temperature on antibody binding characteristics in living cells: A case study, Biomed. Rep., 7, 400, 10.3892/br.2017.982

Coloma, 2000, Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor, Pharm. Res., 17, 266, 10.1023/A:1007592720793

Prigent, 1990, Identification of epitopes on the human insulin receptor reacting with rabbit polyclonal antisera and mouse monoclonal antibodies, J. Biol. Chem., 265, 9970, 10.1016/S0021-9258(19)38765-4

Pardridge, 1995, Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate, Pharm. Res., 12, 807, 10.1023/A:1016244500596

Soos, 1989, Monoclonal antibodies to the insulin receptor mimic metabolic effects of insulin but do not stimulate receptor autophosphorylation in transfected NIH 3T3 fibroblasts, Proc. Natl. Acad. Sci. USA, 86, 5217, 10.1073/pnas.86.14.5217

Soos, 1986, Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor, Biochem. J., 235, 199, 10.1042/bj2350199

Jones, 2020, Lung Endothelial Transcytosis, Compr. Physiol., 10, 491, 10.1002/cphy.c190012

Liu, 2020, Effect of Calcium ion on synaptotagmin-like protein during pre-fusion of vesicle for exocytosis in blood-brain barrier, Biochem. Biophys. Rep., 24, 100845

Hadzhieva, 2017, Impact of Antigen Density on the Binding Mechanism of IgG Antibodies, Sci. Rep., 7, 3767, 10.1038/s41598-017-03942-z

Suzuki, A., Yamasaki, T., Hasebe, R., and Horiuchi, M. (2019). Enhancement of binding avidity by bivalent binding enables PrPSc-specific detection by anti-PrP monoclonal antibody 132. PLoS ONE, 14.

Gruszczyk, 2018, Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax, Science, 359, 48, 10.1126/science.aan1078

Couch, 2013, Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier, Sci. Transl. Med., 5, 183ra157, 10.1126/scitranslmed.3005338

Gustavsson, 2020, SPECT imaging of distribution and retention of a brain-penetrating bispecific amyloid-beta antibody in a mouse model of Alzheimer’s disease, Transl. Neurodegener., 9, 37, 10.1186/s40035-020-00214-1

Hinke, 2018, Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibody, Mol. Metab., 10, 87, 10.1016/j.molmet.2018.01.014

Ciechanover, 1983, Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents, J. Biol. Chem., 258, 9681, 10.1016/S0021-9258(17)44551-0

McGraw, 1990, Human transferrin receptor internalization is partially dependent upon an aromatic amino acid on the cytoplasmic domain, Cell Regul., 1, 369, 10.1091/mbc.1.4.369

Mayle, 2012, The intracellular trafficking pathway of transferrin, Biochim. Biophys. Acta, 1820, 264, 10.1016/j.bbagen.2011.09.009

Skarlatos, 1995, Transport of [125I]transferrin through the rat blood-brain barrier, Brain Res., 683, 164, 10.1016/0006-8993(95)00363-U

Sato, 1991, Receptor-recycling model of clearance and distribution of insulin in the perfused mouse liver, Diabetologia, 34, 613, 10.1007/BF00400989

Duffy, 1987, Blood-brain barrier transcytosis of insulin in developing rabbits, Brain Res., 420, 32, 10.1016/0006-8993(87)90236-8

Cornford, 1998, Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood-brain barrier, J. Cereb. Blood Flow Metab., 18, 26, 10.1097/00004647-199801000-00003

Liddelow, 2010, Development of the lateral ventricular choroid plexus in a marsupial, Monodelphis domestica, Cereb. Fluid Res., 7, 16, 10.1186/1743-8454-7-16

Gjedde, 1984, Estimates of Michaelis-Menten constants for the two membranes of the brain endothelium, J. Cereb. Blood Flow Metab., 4, 241, 10.1038/jcbfm.1984.33

Khan, 2018, Quantification of kinetic rate constants for transcytosis of polymeric nanoparticle through blood-brain barrier, Biochim. Biophys. Acta Gen. Subj., 1862, 2779, 10.1016/j.bbagen.2018.08.020

Boado, 2016, Very High Plasma Concentrations of a Monoclonal Antibody against the Human Insulin Receptor Are Produced by Subcutaneous Injection in the Rhesus Monkey, Mol. Pharm., 13, 3241, 10.1021/acs.molpharmaceut.6b00456

Boado, 2013, IgG-enzyme fusion protein: Pharmacokinetics and anti-drug antibody response in rhesus monkeys, Bioconjug. Chem., 24, 97, 10.1021/bc3005123

Kanzaki, 2020, Surface plasmon resonance analysis of complex formation of therapeutic recombinant lysosomal enzymes with domain 9 of human cation-independent mannose 6-phosphate receptor, Mol. Genet. Metab. Rep., 25, 100639

Kleven, 2018, Transferrin Receptors TfR1 and TfR2 Bind Transferrin through Differing Mechanisms, Biochemistry, 57, 1552, 10.1021/acs.biochem.8b00006

Ng, 2002, An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells, Proc. Natl. Acad. Sci. USA, 99, 10706, 10.1073/pnas.162362999

Ng, 2006, Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor, Blood, 108, 2745, 10.1182/blood-2006-04-020263

Zhou, 2011, Chronic dosing of mice with a transferrin receptor monoclonal antibody-glial-derived neurotrophic factor fusion protein, Drug Metab. Dispos., 39, 1149, 10.1124/dmd.111.038349

Castellanos, D.M., Sun, J., Yang, J., Ou, W., Zambon, A.C., Pardridge, W.M., and Sumbria, R.K. (2020). Acute and Chronic Dosing of a High-Affinity Rat/Mouse Chimeric Transferrin Receptor Antibody in Mice. Pharmaceutics, 12.